Psychopharmacology,
Год журнала:
2024,
Номер
unknown
Опубликована: Дек. 26, 2024
Despite
the
growing
scientific
interest
on
mitragynine,
primary
alkaloid
in
kratom
(Mitragyna
Speciosa),
there
is
a
lack
of
clinical
trials
humans.
This
phase
1
study
aimed
to
evaluate
mitragynine's
safety
profile
and
acute
effects
subjective
drug
experience,
neurocognition,
pain
tolerance.
A
placebo-controlled,
single-blind,
within-subjects
was
conducted
two
parts.
In
part
A,
eight
healthy
human
volunteers
received
placebo
three
doses
mitragynine
(5,
10,
20
mg)
sequential
dosing
scheme,
separate
days.
B,
second
group
seven
40
mg
mitragynine.
Vital
signs,
neurocognitive
function,
tolerance
were
measured
at
regular
intervals
for
7
h
after
administration.
Overall,
did
not
affect
most
outcome
measures
any
dose.
Yet,
lowest
dose
(5
increased
ratings
arousal
attention,
accuracy
sustained
attention
task,
motor
inhibition.
The
highest
(40
amnesia
produced
mild
psychopathological
symptoms.
Mitragynine
significantly
vital
only
mild,
transient
side
reported.
present
suggests
that
low
(5–10
may
cause
feelings
stimulation
enhance
while
inhibitory
distress.
up
well
tolerated
this
group.
Expert Review of Clinical Pharmacology,
Год журнала:
2024,
Номер
17(2), С. 131 - 142
Опубликована: Янв. 13, 2024
Introduction
Kratom
(Mitragyna
speciosa)
has
generated
substantial
clinical
and
scientific
interest
as
a
complex
natural
product.
Its
predominant
alkaloid
mitragynine
several
stereoisomers
have
been
studied
for
activity
in
opioid,
adrenergic,
serotonin
receptors.
While
awaiting
trial
results,
the
pre-clinical
evidence
suggests
range
of
potential
therapeutic
applications
kratom
with
careful
consideration
adverse
effects.
JAMA Network Open,
Год журнала:
2024,
Номер
7(1), С. e2353401 - e2353401
Опубликована: Янв. 26, 2024
Importance
Kratom
products,
which
are
sold
legally
in
most
of
the
US,
contain
alkaloids
with
opioidergic,
adrenergic,
and
serotonergic
activity.
Millions
people
use
kratom
to
relieve
pain,
improve
mood,
or
self-manage
substance
disorders
(SUDs).
has
primarily
been
examined
via
surveys,
recall
biases
among
satisfied
users
may
lead
minimization
transient
negative
outcomes.
Further
prospective
study
use,
such
as
ecological
momentary
assessment
(EMA),
is
needed.
Objective
To
characterize
proximal
motivators,
effects,
patterns
assess
whether
frequency
associated
motivations,
past-year
criteria
for
SUD
(KUD),
other
use.
Design,
Setting,
Participants
For
this
cross-sectional
study,
an
intensive
longitudinal
smartphone-based
EMA
participants’
current
behaviors
experiences
were
repeatedly
sampled
real
time
was
conducted
between
July
1
October
31,
2022.
comprised
a
convenience
sample
US
adults
who
used
at
least
3
days
per
week
4
weeks
online
screening.
Criteria
KUD
based
on
Diagnostic
Statistical
Manual
Mental
Disorders,
Fifth
Edition
.
Data
analysis
performed
November
2022
2023.
Exposure
The
exposure
13
401
kratom-use
events
across
15
days.
Main
Outcomes
Measures
A
baseline
survey
covering
demographics,
health,
attitudes
behaviors,
administered
before
EMA.
following
entries
then
collected:
event-contingent
(product,
dose,
motivations),
follow-up
(short-term
effects
consequences
events),
random-prompt
(mood),
beginning-of-day
(effects
sleep),
end-of-day
(daily
subjective
descriptions
effects).
Bayesian
regression
estimate
means
credible
intervals.
Results
total
357
participants
completed
Their
mean
(SD)
age
38.0
(11.1)
years;
more
than
half
men
(198
[55.5%]).
reported
overall
motivators
that
involved
managing
psychiatric
problems,
but
evaluated
during
situation-specific
needs
increasing
energy
productivity
decreasing
pain.
Acute
considered
congruent
daily
obligations.
Use
patterns,
despite
having
some
distinguishing
features,
generally
similar
their
effects;
predominantly
daytime
seemed
find
frequencies
suited
needs.
Higher
symptoms
physical
dependence
(eg,
withdrawal
tolerance).
Co-used
substances
included
caffeine,
nicotine,
vitamins,
cannabis.
Conclusions
Relevance
Most
using
seemingly
nonproblematic
way.
When
appeared
problematic,
key
element
usually
avoidance
became
motivator.
Longitudinal
studies
examining
changes
over
Journal of Addiction Medicine,
Год журнала:
2024,
Номер
18(2), С. 144 - 152
Опубликована: Янв. 3, 2024
Introduction
Use
of
kratom
has
outpaced
systematic
study
its
effects,
with
most
studies
reliant
on
retrospective
self-report.
Methods
We
aimed
to
assess
acute
effects
following
use
in
adults
who
regularly,
and
quantify
alkaloids
the
products,
urine,
plasma.
Between
July
November
2022,
10
came
our
clinic
orally
self-administered
their
typical
dose;
blinding
procedures
were
not
used.
Physiological
measures
included
blood
pressure,
respiratory
rate,
heart
pulse
oximetry,
temperature,
pupil
diameter.
Subjective
outcomes
Opioid
Withdrawal
Scale,
Addiction
Research
Center
Inventory,
Drug
Effects
Questionnaire.
Psychomotor
performance
was
also
assessed.
Results
Participants
6
men
4
women,
mean
age
41.2
years.
Nine
non-Hispanic
White;
1
biracial.
They
had
used
for
6.6
years
(SD,
3.8
years)
average
(2.0–14.1).
Sessions
190.89
minutes
15.10
minutes).
Mean
session
dose
5.16
g
(median,
4.38
g;
range,
1.1–10.9
g)
leaf
powder.
Relative
baseline,
physiological
changes
minor.
However,
diameter
decreased
(right,
b
=
−0.70,
P
<
0.01;
left,
−0.73,
0.01)
40–80
postdose
remained
below
baseline
>160
minutes.
Scale
pre-dosing
mild
(5.5
±
3.3)
(b
[−4.0,
−2.9],
0.01).
Questionnaire
“feeling
effects”
increased
40/100
30.5)
within
40
above
80
120
19.0,
0.04),
peaking
at
72.7/100;
participants
rated
euphoria
as
Inventory
Morphine-Benzedrine-scale.
did
reliably
improve
or
deteriorate
postdosing.
Conclusions
Among
regular
consumers,
we
found
few
clinically
significant
differences
pre-
post-kratom
dosing.
Alkaloidal
contents
products
expected
ranges.
Frontiers in Pharmacology,
Год журнала:
2024,
Номер
15
Опубликована: Июнь 3, 2024
Although
kratom
use
has
been
part
of
life
for
centuries
in
Southeast
Asia,
the
availability
and
United
States
(US)
increased
substantially
since
early
2000s
when
there
was
little
information
on
pharmacology,
patterns,
effects,
all
critical
to
guiding
regulation
policy.
Here
we
provide
a
synthesis
research
with
several
hundred
English-language
papers
published
past
5
years
drawing
from
basic
research,
epidemiological
surveillance
data,
recent
clinical
research.
This
review
available
literature
aims
an
integrated
update
regarding
our
current
understanding
kratom’s
benefits,
risks,
epidemiology,
which
may
inform
States-based
regulation.
Recent
indicates
are
likely
million
past-year
consumers,
though
estimates
vary
widely.
Even
without
precise
prevalence
is
no
longer
niche,
millions
adults
using
it
myriad
reasons.
Despite
its
botanical
origins
coffee
tree
family
polypharmacy,
popularly
characterized
as
opioid
presumed
opioid-system-based
risks
addiction
or
overdose.
Neuropharmacology,
toxicology,
epidemiology
studies
show
that
more
accurately
substance
diverse
complex
pharmacology.
Taken
together
work
reviewed
here
provides
foundation
future
scientific
studies,
well
guide
ongoing
efforts
regulate
kratom.
also
informs
much-needed
federal
oversight,
including
by
Food
Drug
Administration.
We
conclude
recommendations
priorities
needed
address
policy
knowledge
gaps
around
this
increasingly
used
product.
Journal of Addiction Medicine,
Год журнала:
2024,
Номер
18(3), С. 306 - 312
Опубликована: Март 5, 2024
Kratom
leaf
products
are
increasingly
consumed
in
the
United
States,
with
many
consumers
reporting
they
experience
beneficial
effects
from
kratom
use.
However,
there
is
a
growing
concern
for
kratom's
potential
to
result
dependence
when
used
regularly.
As
such,
we
sought
assess,
using
Diagnostic
and
Statistical
Manual
of
Mental
Disorders
,
(DSM-5)
diagnostic
criteria
substance
use
disorder,
prevalence
"kratom
disorder"
(KUD)
among
consumers.
Frontiers in Pharmacology,
Год журнала:
2024,
Номер
15
Опубликована: Июнь 14, 2024
Background
“Kratom”
refers
to
an
array
of
bioactive
products
derived
from
Mitragyna
speciosa
,
a
tree
indigenous
Southeast
Asia.
Most
kratom
consumers
report
analgesic
and
stimulatory
effects,
common
reasons
for
use
are
address
mental
physical
health
needs,
manage
pain,
reduce
other
substances.
Natural-history
studies
survey
suggest
that
many
perceive
benefits
those
uses,
but
such
unlikely
capture
the
full
range
kratom-use
experiences.
Methods
We
collected
text
data
Reddit
posts
2020-2022
qualitatively
examine
conceptualizations,
motivations,
consequences
associated
with
among
people
posting
social
media.
mentioning
were
studied
using
template
thematic
analysis,
which
included
collecting
descriptions
product
types
practices.
Network
analyses
coded
themes
was
performed
independent
relationships
themes,
between
types.
Results
Codes
applied
329
370
comprised
final
sample;
134
contained
descriptions.
As
accounts
functionally
anonymous,
demographic
estimates
untenable.
Themes
dependence
(tolerance,
withdrawal,
or
avoid
withdrawal),
perceived
addiction
(net
detrimental
effects
on
functioning),
quitting.
Extract
positively
reports
addiction,
dependence,
experiences
quitting
kratom.
Many
used
energy
self-treatment
fatigue,
problems
opioid
alcohol;
they
these
uses
as
effective.
Consumers
expressed
frustrations
about
inconsistencies
lack
information.
Conclusion
in
previous
studies,
deemed
helpful
some
hindrance
others,
we
also
found
evidence
notable
negative
have
not
been
well
documented
surveys.
Daily
may
produce
mild-moderate
greater
severity
being
possibly
more
concentrated
extracts;
however,
there
currently
no
human
laboratory
extracts.
Such
detailed
information,
needed
help
inform
consumer
decision-making.
Traffic Injury Prevention,
Год журнала:
2024,
Номер
25(4), С. 594 - 603
Опубликована: Март 18, 2024
Objectives
Despite
widespread
kratom
use,
there
is
a
lack
of
knowledge
regarding
its
effects
on
driving.
We
evaluated
the
self-reported
driving
behaviors
consumers
and
assessed
their
simulated-driving
performance
after
self-administering
products.
The American Journal of Drug and Alcohol Abuse,
Год журнала:
2025,
Номер
unknown, С. 1 - 13
Опубликована: Янв. 30, 2025
Background:
Kratom
is
a
plant
with
alkaloids
acting
at
opioid,
serotonergic,
adrenergic,
and
other
receptors.
Consumers
report
numerous
use
motivations.